Cargando…

Carbapenemase Producers Among Extensive Drug-Resistant Gram-Negative Pathogens Recovered from Febrile Neutrophilic Patients in Egypt

PURPOSE: This study aimed to detect the prevalence of carbapenemase producers (CPs) among extensive drug-resistant (XDR)-carbapenemase producing Gram-negative bacteria (GNB) recovered from various clinical specimens of hospitalized neutrophilic febrile patients in two major tertiary care hospitals i...

Descripción completa

Detalles Bibliográficos
Autores principales: Mabrouk, Samar S, Abdellatif, Ghada R, El-Ansary, Mona R, Aboshanab, Khaled M, Ragab, Yasser M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7495499/
https://www.ncbi.nlm.nih.gov/pubmed/32982326
http://dx.doi.org/10.2147/IDR.S269971
_version_ 1783582935620780032
author Mabrouk, Samar S
Abdellatif, Ghada R
El-Ansary, Mona R
Aboshanab, Khaled M
Ragab, Yasser M
author_facet Mabrouk, Samar S
Abdellatif, Ghada R
El-Ansary, Mona R
Aboshanab, Khaled M
Ragab, Yasser M
author_sort Mabrouk, Samar S
collection PubMed
description PURPOSE: This study aimed to detect the prevalence of carbapenemase producers (CPs) among extensive drug-resistant (XDR)-carbapenemase producing Gram-negative bacteria (GNB) recovered from various clinical specimens of hospitalized neutrophilic febrile patients in two major tertiary care hospitals in Egypt. METHODS: Standard methods were used to evaluate the antimicrobial susceptibility of clinical isolates according to the guidelines of the Clinical and Laboratory Standards Institute (CLSI). Phenotypic and genotypic analysis of CPs were carried out and statistically analyzed using standard methods. RESULTS: Three hundred and forty-two GNB were obtained from 342 clinical specimens during the period of the study, where 162 (47%) were enterobacterial isolates, including, 63 (18.4%) Escherichia coli, 87 (25.4%) Klebsiella spp., 5 (1.46%) Enterobacter cloacae, 5 (1.46%) Salmonella spp. and 2 (0.6%) Proteus and 180 (53%) were non-fermentative bacilli including, 129 (37.7%), Acinetobacter baumannii, and 51 (14.9%), Pseudomonas spp. Out of the 342 GNB, 188 (54.9%) isolates were multi-drug resistant (MDR). Of these, 52 (27.6%) were XDR as well as CPs as confirmed phenotypically. The MIC of imipenem against the XDR GNB against showed either low (11 isolates; 21.1%; MIC range =4–32 µg/mL) or high levels of resistance (41 isolates; 78.8%; MIC range = 64-≥1024). The most prevalent carbapenem resistance (CR) genes were blaKPC (63.5%) followed by blaOXA-48 (55.7%) and blaVIM (28.8%). No significant association could be observed between the MIC level and the presence of CR genes (P value >0.05). CONCLUSION: High prevalence of MDR (54.9%) and XDR (27.6%) GNB pathogens associated with high levels of resistance to carbapenems were observed. All XDR GNB were CPs and tested positive for at least one of the CR genes. However, most of them (78.8%) showed a high level of CR (MIC range = 64-≥1024) with no significant association with the CR genes.
format Online
Article
Text
id pubmed-7495499
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-74954992020-09-24 Carbapenemase Producers Among Extensive Drug-Resistant Gram-Negative Pathogens Recovered from Febrile Neutrophilic Patients in Egypt Mabrouk, Samar S Abdellatif, Ghada R El-Ansary, Mona R Aboshanab, Khaled M Ragab, Yasser M Infect Drug Resist Original Research PURPOSE: This study aimed to detect the prevalence of carbapenemase producers (CPs) among extensive drug-resistant (XDR)-carbapenemase producing Gram-negative bacteria (GNB) recovered from various clinical specimens of hospitalized neutrophilic febrile patients in two major tertiary care hospitals in Egypt. METHODS: Standard methods were used to evaluate the antimicrobial susceptibility of clinical isolates according to the guidelines of the Clinical and Laboratory Standards Institute (CLSI). Phenotypic and genotypic analysis of CPs were carried out and statistically analyzed using standard methods. RESULTS: Three hundred and forty-two GNB were obtained from 342 clinical specimens during the period of the study, where 162 (47%) were enterobacterial isolates, including, 63 (18.4%) Escherichia coli, 87 (25.4%) Klebsiella spp., 5 (1.46%) Enterobacter cloacae, 5 (1.46%) Salmonella spp. and 2 (0.6%) Proteus and 180 (53%) were non-fermentative bacilli including, 129 (37.7%), Acinetobacter baumannii, and 51 (14.9%), Pseudomonas spp. Out of the 342 GNB, 188 (54.9%) isolates were multi-drug resistant (MDR). Of these, 52 (27.6%) were XDR as well as CPs as confirmed phenotypically. The MIC of imipenem against the XDR GNB against showed either low (11 isolates; 21.1%; MIC range =4–32 µg/mL) or high levels of resistance (41 isolates; 78.8%; MIC range = 64-≥1024). The most prevalent carbapenem resistance (CR) genes were blaKPC (63.5%) followed by blaOXA-48 (55.7%) and blaVIM (28.8%). No significant association could be observed between the MIC level and the presence of CR genes (P value >0.05). CONCLUSION: High prevalence of MDR (54.9%) and XDR (27.6%) GNB pathogens associated with high levels of resistance to carbapenems were observed. All XDR GNB were CPs and tested positive for at least one of the CR genes. However, most of them (78.8%) showed a high level of CR (MIC range = 64-≥1024) with no significant association with the CR genes. Dove 2020-09-11 /pmc/articles/PMC7495499/ /pubmed/32982326 http://dx.doi.org/10.2147/IDR.S269971 Text en © 2020 Mabrouk et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Mabrouk, Samar S
Abdellatif, Ghada R
El-Ansary, Mona R
Aboshanab, Khaled M
Ragab, Yasser M
Carbapenemase Producers Among Extensive Drug-Resistant Gram-Negative Pathogens Recovered from Febrile Neutrophilic Patients in Egypt
title Carbapenemase Producers Among Extensive Drug-Resistant Gram-Negative Pathogens Recovered from Febrile Neutrophilic Patients in Egypt
title_full Carbapenemase Producers Among Extensive Drug-Resistant Gram-Negative Pathogens Recovered from Febrile Neutrophilic Patients in Egypt
title_fullStr Carbapenemase Producers Among Extensive Drug-Resistant Gram-Negative Pathogens Recovered from Febrile Neutrophilic Patients in Egypt
title_full_unstemmed Carbapenemase Producers Among Extensive Drug-Resistant Gram-Negative Pathogens Recovered from Febrile Neutrophilic Patients in Egypt
title_short Carbapenemase Producers Among Extensive Drug-Resistant Gram-Negative Pathogens Recovered from Febrile Neutrophilic Patients in Egypt
title_sort carbapenemase producers among extensive drug-resistant gram-negative pathogens recovered from febrile neutrophilic patients in egypt
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7495499/
https://www.ncbi.nlm.nih.gov/pubmed/32982326
http://dx.doi.org/10.2147/IDR.S269971
work_keys_str_mv AT mabrouksamars carbapenemaseproducersamongextensivedrugresistantgramnegativepathogensrecoveredfromfebrileneutrophilicpatientsinegypt
AT abdellatifghadar carbapenemaseproducersamongextensivedrugresistantgramnegativepathogensrecoveredfromfebrileneutrophilicpatientsinegypt
AT elansarymonar carbapenemaseproducersamongextensivedrugresistantgramnegativepathogensrecoveredfromfebrileneutrophilicpatientsinegypt
AT aboshanabkhaledm carbapenemaseproducersamongextensivedrugresistantgramnegativepathogensrecoveredfromfebrileneutrophilicpatientsinegypt
AT ragabyasserm carbapenemaseproducersamongextensivedrugresistantgramnegativepathogensrecoveredfromfebrileneutrophilicpatientsinegypt